文献速递肺外科

黑色素瘤肺转移灶切除术后的临床结局:一项基于人群的研究

Clinical Outcomes After Pulmonary Metastasectomy for Melanoma: A Population-Based Study.
PubMed 文献 · Ann Thorac Surg · 2018-08-29

该研究基于加拿大安大略省人群登记数据,纳入2004至2012年间99例因皮肤黑色素瘤肺转移行肺切除术的患者,报告总体生存并采用多因素Cox回归分析。术后60天死亡率为0%,自切除时起2年和5年总体生存分别为44%和21%;病变更大与生存更差及切缘阳性相关。

要点

  • 99例皮肤黑色素瘤肺转移切除患者,术后60天死亡率为0%。
  • 自切除时起2年和5年总体生存分别为44%和21%。
  • 病变更大与生存更差相关,且与切缘阳性相关。

核心结论

  • 在这项未选择的人群研究中,黑色素瘤肺转移切除术后21%的患者为5年生存者,病变更大者生存更差,病变更大与切缘阳性相关。

研究设计与样本

  • 基于人群的登记研究,纳入加拿大安大略省2004至2012年间因皮肤黑色素瘤行肺转移灶切除的全部病例,共99例,采用多因素Cox回归分析。

主要发现

  • 99例患者平均年龄58岁,术后60天死亡率为0%。
  • 自切除时起2年和5年总体生存分别为44%(95%CI:34%至54%)和21%(95%CI:12%至31%)。
  • 2年总体生存:病灶大小小于1.5 cm者为57%(95%CI:35%至73%),1.5至2.2 cm者为43%(95%CI:26%至59%),2.2 cm或以上者为35%(95%CI:19%至52%)。
  • 多因素逐步选择模型中唯一显著变量为病灶大小2.3 cm或以上(HR 1.64,95%CI:1.001至2.68)。
  • 病变更大与切缘阳性相关(p=0.04);切缘阳性者无超过2年的生存者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Resection of pulmonary metastases is an important treatment option for patients with oligometastatic melanoma. There are currently no published data available on population-level outcomes. Here, we report outcomes of a registry-based study of patients who underwent lung resection for cutaneous melanoma metastases. METHODS: The study population was all cases of cutaneous melanoma in Ontario, Canada, with resection of pulmonary metastases from 2004 to 2012. Melanoma cases were identified using the population-based Ontario Cancer Registry and were linked with hospital records to identify thoracic surgery. Pathology reports from the Ontario Cancer Registry were used to confirm the histology of resected lesions and determine tumor-related prognostic factors. Overall survival was described, and multivariable Cox regression utilized. RESULTS: Ninety-nine patients underwent resection of cutaneous melanoma lung metastases. Mean age was 58 years. Sixty-day postoperative mortality was 0%. Two-year and 5-year overall survival from time of resection was 44% and 21%, respectively (95% confidence intervals: 34% to 54% and 12% to 31%, respectively). Two-year overall survival was 57% for lesion size less than 1.5 cm; 43% for lesion size 1.5 to 2.2 cm; and 35% for lesion size 2.2 cm or greater (confidence intervals: 35% to 73%, 26% to 59%, and 19% to 52%, respectively). In the multivariable stepwise selected model, the only significant variable was size 2.3 cm or greater (hazard ratio 1.64, confidence interval: 1.001 to 2.68). Greater lesion size was correlated with positive margin status (p = 0.04); there were no survivors beyond 2 years with positive margins. CONCLUSIONS: In this unselected population-based study, 21% of patients were 5-year survivors after pulmonary metastasectomy for melanoma. There was worse survival with greater lesion size. Greater lesion size was associated with positive margin status.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Hanna TP, Chauvin C, Miao Q, et al. Clinical Outcomes After Pulmonary Metastasectomy for Melanoma: A Population-Based Study. Ann Thorac Surg. 2018. PMID: 30171851. doi:10.1016/j.athoracsur.2018.06.078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。